Reverse Transcriptase Inhibitors

Reverse transcriptase inhibitors (RTIs) are a group of antiviral drugs used to treat HIV/AIDS, hepatitis B, and other viral infections. RTIs work by preventing reverse transcriptase, a viral enzyme, from copying the genetic material (RNA) of a virus into the genetic material (DNA) of a host cell. This prevents the virus from replicating and spreading within the body. RTIs are a key part of antiretroviral therapies that help reduce the spread of HIV and improve the quality of life for people living with HIV/AIDS.

← International Journal of Personalized Medicine

Related Articles

6 article(s) found

A Rare Cause of Fever of Unknown Origin: Reverse Shapiro’s Syndrome

Full-text HTML Download PDF Download XML

Docking Studies of HIV-1 Reverse Transcriptase and HIV-1 Protease with Phytocompounds of Carissa Carandas L.

Full-text HTML Download PDF Download XML

Nucleoside and Nucleotide Reverse Transcriptase Inhibitors Induce Aging by Inhibiting Telomerase Function

Full-text HTML Download PDF Download XML

Stem Cell Differentiation Stage Factors (SCDSFs) Taken from Zebrafish Embryo during Organogenesis and their Role as Epigenetics Regulators able to Reverse Neurosensory Hearing Loss

Full-text HTML Download PDF Download XML

Cross-Reactivity between COX-2 Inhibitors in Patients with Cross-Reactive Hypersensitivity to NSAIDs

Full-text HTML Download PDF Download XML

Natural Polyphenols as Inhibitors for the Binding of Covid-19 S-RBD with ACE-2

Full-text HTML Download PDF Download XML